Cargando…
Neurofilament light in blood – What more is needed for clinical implementation in multiple sclerosis?
Autor principal: | Zetterberg, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317184/ https://www.ncbi.nlm.nih.gov/pubmed/32574951 http://dx.doi.org/10.1016/j.ebiom.2020.102826 |
Ejemplares similares
-
Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022) -
Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation
por: Gafson, Arie R., et al.
Publicado: (2022) -
Neurofilaments in progressive multiple sclerosis: a systematic review
por: Williams, Thomas, et al.
Publicado: (2020) -
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
por: Novakova, Lenka, et al.
Publicado: (2017) -
The prognostic significance of early blood neurofilament light chain concentration and magnetic resonance imaging variables in relapse‐onset multiple sclerosis
por: Williams, Thomas, et al.
Publicado: (2022)